Targeted Therapy for Medullary Thyroid Cancer: A Review

Medullary thyroid cancers (MTCs) constitute between 2 and 5% of all thyroid cancers. The 10-year overall survival (OS) rate of patients with localized disease is around 95% while that of patients with regional stage disease is about 75%. Only 20% of patients with distant metastases at diagnosis surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Priya, S. R., Dravid, Chandra Shekhar, Digumarti, Raghunadharao, Dandekar, Mitali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635342/
https://www.ncbi.nlm.nih.gov/pubmed/29057215
http://dx.doi.org/10.3389/fonc.2017.00238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635342/
https://www.ncbi.nlm.nih.gov/pubmed/29057215
http://dx.doi.org/10.3389/fonc.2017.00238

Ejemplares similares